Abstract. This study is the first to use 10-to 90-kg tissue-equivalent phantoms as patient surrogates to measure peripheral skin doses (D skin ) in lung cancer treatment through Volumetric Modulated Arc Therapy of the Axesse linac. Five tissueequivalent and Rando phantoms were used to simulate lung cancer patients using the thermoluminescent dosimetry (TLD-100H) approach. TLD-100H was calibrated using 6 MV photons coming from the Axesse linac. Then it was inserted into phantom positions that closely corresponded with the position of the represented organs and tissues. TLDs were measured using the Harshaw 3500 TLD reader. The ICRP 60 evaluated the mean D skin to the lung cancer for 1 fraction (7 Gy) undergoing VMAT. The D skin of these phantoms ranged from 0.51±0.08 (10-kg) to 0.22±0.03 (90-kg) mSv/Gy. Each experiment examined the relationship between the D skin and the distance from the treatment field. These revealed strong variations in positions close to the tumor center. The correlation between D skin and body weight was D skin (mSv) = -0.0034x + 0.5296, where x was phantom's weight in kg. R 2 is equal to 0.9788. This equation can be used to derive an equation for lung cancer in males. Finally, the results are compared to other published research. These findings are pertinent to patients, physicians, radiologists, and the public.
The medical linear accelerator (linac), Axesse (Elekta Inc, Maryland, USA), can provide photon energies with accelerating voltages of 6 MV that can deliver Volumetric Modulated Arc Therapy (VMAT). VMAT is a powerful technique for irradiating many treatment sites and obtaining higher dose conformity to the tumor; it also decreases intra-fraction movements because of its shorter delivery times [1] . During treatment, the patient was exposed to significantly undesirable radiation that was primarily caused by out-of-field radiation resulting from collimators and beam modifiers. It is necessary to estimate the accompanying extra radiation to estimate the (peripheral) skin doses (D skin ) for patients. The peripheral dose was defined as the radiation dose anywhere outside the treatment field; it was composed of the scatter dose and the leakage dose. These authors are aware of no studies assessing D skin that results from differences in patient weights from the linac; no comparisons can be made between previous studies of the D skin of different body-weights for VMAT lung cancer treatment [2, 3] . However, the D skin is a matter of concern. This study is the first to develop different bodyweight indigenous tissue-equivalent phantoms as patient surrogates, ranging from 10-to 90-kg, using thermoluminescent dosimetry (TLD-100H) (3.0×3.0×1.0 mm 3 , Harshaw, OH, USA) [4, 5] . Intensive efforts should establish a more reliable and practical method for quantitative measurement of patients' D skin , to effectively provide the data to improve radiation safety.
Material and methods

Tissue-equivalent phantom
This study developed five tissue-equivalent phantoms of 10-, 30-, 50-, 70-, and 90-kg. Anthropometric-shaped skeletons constructed from epoxy-resin and polymethylmethacrylate (PMMA) were used to simulate patients [4, 6] . The phantom was designed based on the GSF-Forshungszentrum fur Umwelt und Gesundheit (Germay) adult mathematical models, and the lung masses were based on the ICRP reference man [4, 7] . The materials' densities are as follows: the lung tissue-equivalent was 0.296, the skeleton-cortical-bone tissue-equivalent was 1.486, and the skin tissue-equivalent was 1.105 g/cm 3 [4, 6] . The phantom was based on the general human design. Each was comprised of 31 slices, representing the head, neck, torso and abdomen, but without arms or legs [4, 6] . Table 1 lists the dimensions and physical properties of the Rando and tissue-equivalent phantoms [4] .
The Rando phantom (Alderson Radiation Therapy Phantom, Radiology Support Devices, Long Beach, CA) is suitable for oncology dose measurements [4] . Figure 1 shows the outer appearance of the five tissue-equivalent and Rando phantoms.
Dosimetry
A total of 31 measurement positions were selected on the anterior central line and are marked as 1- 31 in Figure 2 . Accordingly, since the D skin, i of each slice is different, the average D skin (i = 1-31) of the ith slice was computed, and D skin, i was substtuted into Eq. (1). The D skin was determined by adding the D i of all scan slices and weighting each with its absorbed dose. D skin , was evaluated from the equation:
where D skin, i is the absorbed dose for phantoms at each slice. These measured TLD were presented the D skin distributions of phantoms [8] .
The TLDs were analyzed using a fully automated Harshaw 3500 reader (Bicron NE, Solon, OH). The element correction coefficient determined the relative sensitivity of these TLDs to correct the variation of each batch's individual sensitivity. All TLDs were pre-annealed at 240 o C for 10 min in a microprocessor-controlled oven via a Barnstead/Thermolyne 47900 Furnace (Thermolyne Co.), followed by a rapid cooling on an aluminum block [4, 5, 9] .
Calibrated TLD-100H using 6MV beams
The TLD-100H was selected for its small dimensions and the response's lower dependence on phton energy, dose rate, and the radiation's direction of incidence. The TLDs were irradiated according to the International Atomic Energy Agency recommendations (TRS-398) by placing the mover on five solid water phantom (SWP) slabs, 30×30 cm 2 in area and 10 mm in thickness, for electronic equilibrium, and then placing a SWP above them, using a skin source distance (SSD) of 100 cm and a 10×10 cm 2 field [4, 5] . As in other studies, a Farmer-type ionization chamber, type NE 2571 (PTW, Freiburg, UNIDOS), which had a volume of 0.6 cc, was positioned in the solid water [4, 5] .
CT simulation and treatment plan of lung cancer
All the computed tomography (CT) images (GE Aquillion 64, Toshiba Medical Solutions, Japan) of the phantoms were transferred and registered in the treatment planning system [1, 2, [10] [11] [12] [13] . Phantoms were introduced into a CT-based simulation in a supine position. Lung treatment plans with Axesse were developed and reviewed by professional medical doctors (Hsien-Chun Tseng, MD) and senior radiotherapists (Hsin-Yi Chu), both with 10 years of experience [4, 6] . The target volume in the 70-kg phantom's lung was 64 cm 3 at a depth of 5 cm. A marker was used to place skin marks in three directions [1, 2, 14] . Figure 3(a) shows the treatment plan of the Pinnacle planning system (Philips The CT images and organ contours were transferred for VMAT at the Department of Radiation Oncology at Chung Shan Medical University Hospital (CSMUH) in Taichung ROC. The prescribed dose was specified at the planning target volume (PTV). Complete prescribed photo doses (700 cGy) of 6 MV were showed in red and delivered to the phantom's PTV in a single treatment.
The protocol required a total dose of 21 Gy to the tumor. Organs at risk are marked as follows: heart (red colorwash); lung 1 (green colorwash); lung 2 (blue colorwash); and spinal cord (cyanine colorwash). The prescribed isodose (21 Gy) is shown in red.
In vivo measurement during VMAT
In vivo measurements were mainly located in the skin. The primary irradiation and extra radiation were measured first in the skin, and then throughout the body. Ninety three of the TLDs were attached to these phantoms at each slice. One-bag of TLDs were inserted into the tumor's center to directly evaluate the tumor dose at the 12 th slice. For all locations, the final D skin was obtained by averaging the three TLDs of each slice [4, 9] . Nine TLD chips were used to measure background radiation at our low-background lab. For each measurement slice, three individually calibrated TLDs packed into one bag yielded three readings. These were averaged to obtain the TLD-measured doses for measuring D skin, i [4] . The error bars represent the uncertainty of the D skin values across the different TLDs in a same slice.
Results and discussions
Uncertainty
The precision and accuracy of the TLD-100H included several parameters, including: 1) TLD counting statistical errors ranging from 3 to 10%, 2) TLD calibrations of 6 MV photons' doseassociated nonlinearity of about 8%, 3) systematic uncertainties ranging from 3 to 8% from the Harshaw 3500 reader, and 4) errors in power fluctuation that came from the Axesse linac were quoted based on monthly clinical quality assurance (QA) less than ± 2%. The total uncertainties ranged from 9.27 to 15.2%
Skin doses (D skin )
Figures 4(a)-4(g) show the in vivo D skin based on the distance from the irradiated tumor center of the phantoms, averaged over a total of five trials. For each phantom, the D skin was normalized independently to 100% of the tumor center dose. Additionally, the D skin that fell off of the treatment plan, outside the scan field displayed, varied significantly and decreased as distance from the tumor center increased. It should be noted that contribution of the D skin, 14 from the 14th slice of Rando phantom remarkably decreased from 100% to 7.73%.
The D skin for the lung cancer treatment exposed to the 6 MV linac indicated large values, reaching up to 0.34±0.04 mSv/Gy for the Rando phantom and 0.51±0.06 (10-kg), 0.41±0.06 (30-kg), 0.35±0.05 (50-kg), 0.31±0.03 (70-kg), and 0.22±0.04 (90-kg) mSv/Gy for the tissue-equivalent phantoms of the ICRP 60 [3, 7] . Eq. (2) Where the D skin was in the mSv/Gy, M denotes the tissue-equivalent phantoms in kg. Figure 5 compares the results of the D skin of the 70-kg and Rando phantoms. The D skin of the 70-kg phantom is 0.31±0.05 mSv/Gy, nearly 0.91 times that of the Rando phantom, at 0.34±0.04 mSv/Gy. The deviation was investigated by the density effect. The highest TLD value was obtained in the 12 th slice of the phantom at 99.8±16.9% of the tumor center, and the lowest D skin was determined in the TLD in slices 27 to 31, which was 0.51±0.09 % of the tumor center.
The in vivo measurements showed that the D skin was dependent on the phantom's weight. The 10-kg phantom's is steeper than the other phantoms'. This indicates that the 10-kg phantom has a relatively high D skin , due to the skin close to the tumor center.
Comparison with other studies of similar investigation types
Dr. Jia showed that the IMRT leakage dose is approximately 6 cGy, and it is uniformly distributed throughout the patient's skin, while the leakage dose from the RapidArc is about 3 cGy with a prescribed dose of 45 Gy [1] . This result fully supports our measurements [1] . In a recent paper, Dr. Tyan used a patient to evaluate in vivo doses of multi-slice computed tomography in abdominal examinations taken by 40-and 64 detector scanners, in-of-plane for males, and by 1.4 to 9.6 mSv (mean dose, 4.1 mSv) for females. His results were higher than those of D skin ranged from 0.51±0.08 (10-kg) to 0.22±0.03 (90-kg) mSv/Gy herein, primarily due to the higher dose conformity to the tumor and the rapid decrease of VMAT of the Axcess linac [8] .
The different results obtained from the above-mentioned studies can be attributed to the differences: (A) in treatment modalities, (B) in the TLDs' distance from the tumor center, (C) in measured approaches, and (D) in linac performance. Additionally, other differences may arise from density inconsistencies between the tissue-equivalent and the anthropomorphic phantoms used. This may be true despite the fact that the specified densities of the tissue-equivalent phantoms are close to Rando phantom. However, these phantoms and the TLD approach can be a useful and reliable method for D skin estimations.
Conclusion
The in vivo D skin measurements reveal a measurable difference between tissue-equivalent phantoms that involving extra peripheral radiations. Among all the phantoms, the 10-kg SDM has the highest D skin . The D skin reached up to 0.34±0.04 mSv/Gy for the Rando phantom. The closer it is to tumor center; the higher dose the skin will receive. The calculated D skin, i clearly show that D skin, decreases with increasing distance. The D skin was highest near the tumor center and decreased with distance from the tumor center. The D skin decreased in an inverse correlation with increasing phantom weight. There was good linearity between each TLD. The highest TLD value was obtained in the 12 th slice of the phantom at 99.8±16.9% of the tumor center. These results indicate that the TLD-100H approach displays high sensitivity and stability. The reported in vivo D skin measurements demonstrate that tissueequivalent phantoms designed using ICRU 48 can provide a reliable method for evaluating D skin radiations as well as applicable for other cancer, such as, lung cancer, head and neck cancer. The quantitative results can provide practical guidance regarding radiation protection.
